• Home
  • Stock
  • Medicamen Biotech Fundamental Analysis
  • Medicamen Biotech Fundamental Analysis

Medicamen Biotech fundamental analysis

MEDICAMEQ

HealthcareSmall

411.6

3.45 (-0.83%)
Last updated on 28 Nov, 2025 | 15:30 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Medicamen Biotech Fundamentals

P/E Ratio

52.07

P/B Ratio

2.08

Div. Yield

0.24

Sector P/E

37.14

Sector P/B

0.85

Sec. Div. Yield

0.56

  • Medicamen Biotech Fundamentals is currently trading with a P/E Ratio of 52.07, compared to the sector average of 37.14. Its P/B Ratio stands at 2.08, while the sector’s is 0.85. In terms of returns, the stock offers a Dividend Yield of 0.24%, which is than the sector’s 0.56%.

Medicamen Biotech Score Card

  • Price

    Attractive

  • Growth

    Moderate

  • Quality

    Poor

  • Management

    Average

  • On its scorecard, Medicamen Biotech reflects: Price – Attractive, Growth – Moderate, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.